← Latest Filings
N

Novo Holdings A/S

Also a 13F filer: see its fund portfolio and quarterly moves →

Open-market buys
1
$10.0M total
Open-market sells
0
$0 total
Tracking since
May 2026
Open-market buy — $10.0M
Avalyn Pharma Inc. · May 1, 2026
Open-market trades from the last two years.
4,180,550 Common Stock in COAG
Held directly · as of 2026-05-04
3,883,289 Voting Common Stock in AVLN
Held directly · as of 2026-05-01
Avalyn Pharma Inc.
CIK 0001540171
Hemab Therapeutics Holdings, Inc.
CIK 0002114044